Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
British Journal of Clinical Pharmacology
|
January 20, 2026
Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review
Bala Swetha Baskaran, Mohammad Ali Omrani, Flory T Muanda
Journal of Psychopharmacology (Oxford, England)
|
July 24, 2025
β-blockers and risk of neuropsychiatric adverse events: An active-comparator restricted disproportionality on the FAERS
Lujain Ez Eddin, Mohammad Ali Omrani, Niaz Chalabianloo, et al.
Journal of Food Protection
|
March 14, 2023
Human Health Risk Assessment and Exposure Evaluation by Monte-Carlo Simulation Method for Aflatoxin M1 in Widely Consumed Infant Dried Powder Milk in Iran
Behnaz Naghshbandi, Mohammad Ali Omrani, Abolfazl Jafari-Sales, et al.
Plos One
|
September 25, 2025
Enhancing adverse drug reaction data quality in Canada: A high-precision pipeline for medication name standardization and enrichment
Niaz Chalabianloo, Sheikh S Abdullah, Mohammad Ali Omrani, et al.
British Journal of Clinical Pharmacology
|
December 10, 2024
β-Blockers and risk of neuropsychiatric disorders: A systematic review and meta-analysis
Lujain Ez Eddin, Rebecca Preyra, Fatemeh Ahmadi, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 27, 2025
Fluoroquinolones and risk of nightmares: A literature review and disproportionality analysis using individual case safety reports from Food and Drug Administration Adverse Event Reporting System database
Mohammad Ali Omrani, Christian T Tsobo, Niaz Chalabianloo, et al.
The Journal of Antimicrobial Chemotherapy
|
July 15, 2025
Trimethoprim/sulfamethoxazole and risk of haemophagocytic lymphohistiocytosis (HLH): a literature review and disproportionality analysis using individual case safety reports from FAERS
Rinko Lau, Hasti Sadeghi, Fatemeh Ahmadi, et al.
Expert Opinion on Drug Safety
|
March 5, 2026
Who is missing from SGLT-2 inhibitor trials? implications for drug safety and seneralizability: a systematic review and meta-analysis
Mohammad Ali Omrani, Bala Swetha Baskaran, Hasti Sadeghi, et al.
The Annals of Pharmacotherapy
|
February 27, 2025
Severe Acute Respiratory Failure Associated With Trimethoprim/Sulfamethoxazole Among Adolescent and Young Adults: An Active Comparator-Restricted Disproportionality Analysis From the FDA Adverse Event Reporting System (FAERS) Database
Fatemeh Ahmadi, Niaz Chalabianloo, Eric McArthur, et al.
The American Journal of Emergency Medicine
|
October 1, 2025
Comparative effectiveness of vasopressin, steroids, and epinephrine-based regimens in cardiac arrest: A network Meta-analysis of clinical trials
Fatemeh Saghafi, Mohammad Hossein Dehghani, Sajjad Erami, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
British Journal of Clinical Pharmacology
|
January 20, 2026
Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review
Bala Swetha Baskaran, Mohammad Ali Omrani, Flory T Muanda
Journal of Psychopharmacology (Oxford, England)
|
July 24, 2025
β-blockers and risk of neuropsychiatric adverse events: An active-comparator restricted disproportionality on the FAERS
Lujain Ez Eddin, Mohammad Ali Omrani, Niaz Chalabianloo, et al.
Journal of Food Protection
|
March 14, 2023
Human Health Risk Assessment and Exposure Evaluation by Monte-Carlo Simulation Method for Aflatoxin M1 in Widely Consumed Infant Dried Powder Milk in Iran
Behnaz Naghshbandi, Mohammad Ali Omrani, Abolfazl Jafari-Sales, et al.
Plos One
|
September 25, 2025
Enhancing adverse drug reaction data quality in Canada: A high-precision pipeline for medication name standardization and enrichment
Niaz Chalabianloo, Sheikh S Abdullah, Mohammad Ali Omrani, et al.
British Journal of Clinical Pharmacology
|
December 10, 2024
β-Blockers and risk of neuropsychiatric disorders: A systematic review and meta-analysis
Lujain Ez Eddin, Rebecca Preyra, Fatemeh Ahmadi, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 27, 2025
Fluoroquinolones and risk of nightmares: A literature review and disproportionality analysis using individual case safety reports from Food and Drug Administration Adverse Event Reporting System database
Mohammad Ali Omrani, Christian T Tsobo, Niaz Chalabianloo, et al.
The Journal of Antimicrobial Chemotherapy
|
July 15, 2025
Trimethoprim/sulfamethoxazole and risk of haemophagocytic lymphohistiocytosis (HLH): a literature review and disproportionality analysis using individual case safety reports from FAERS
Rinko Lau, Hasti Sadeghi, Fatemeh Ahmadi, et al.
Expert Opinion on Drug Safety
|
March 5, 2026
Who is missing from SGLT-2 inhibitor trials? implications for drug safety and seneralizability: a systematic review and meta-analysis
Mohammad Ali Omrani, Bala Swetha Baskaran, Hasti Sadeghi, et al.
The Annals of Pharmacotherapy
|
February 27, 2025
Severe Acute Respiratory Failure Associated With Trimethoprim/Sulfamethoxazole Among Adolescent and Young Adults: An Active Comparator-Restricted Disproportionality Analysis From the FDA Adverse Event Reporting System (FAERS) Database
Fatemeh Ahmadi, Niaz Chalabianloo, Eric McArthur, et al.
The American Journal of Emergency Medicine
|
October 1, 2025
Comparative effectiveness of vasopressin, steroids, and epinephrine-based regimens in cardiac arrest: A network Meta-analysis of clinical trials
Fatemeh Saghafi, Mohammad Hossein Dehghani, Sajjad Erami, et al.
Page
of 2